Brinker Capital Investments, LLC Haemonetics Corp Transaction History

Brinker Capital Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$49.27 - $66.08 $796,301 - $1.07 Million	-16,162 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $316,588 - $457,270	7,233 Added 81.01%	16,162 $1.02 Million
Q4 2021 Feb 08, 2022	SELL	$49.55 - $74.59 $461,954 - $695,402	-9,323 Reduced 51.08%	8,929 $474,000
Q2 2021 Aug 03, 2021	BUY	$51.81 - $118.56 $212,731 - $486,807	4,106 Added 29.03%	18,252 $1.22 Million
Q1 2021 May 12, 2021	BUY	$111.01 - $139.48 $1.57 Million - $1.97 Million	14,146 New	14,146 $1.57 Million

Q1 2020 May 13, 2020	SELL	$74.34 - $121.82 $4,163 - $6,821	-56 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$114.37 - $129.46 $6,404 - $7,249	56 New	56 $6,000

310

50.1M

161K

56.3K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.25B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.